UCL Faculty of Brain Sciences partners with external organisations to share the knowledge of our students and academics and to strengthen and deepen the impact of our research in the 'real world.'
Santen and University College London to collaborate on ophthalmic research and education
Santen Pharmaceutical Co., Ltd. (Santen) and UCL (University College London) announced a Memorandum of Understanding (MoU) to collaborate on ophthalmic research and education.
As part of the collaboration, Santen will conduct research programs with scientists in the UCL Institute of Ophthalmology, and provide PhD candidates with important funding support.
UCL and the global pharmaceutical company Eisai forms a major strategic alliance
Neurological disorders such as Alzheimer’s and Parkinson’s are among the most pressing problems facing the world’s health providers. It’s against this background that in December 2012 UCL and the global pharmaceutical company Eisai formed a major strategic alliance with the aim of discovering and developing novel therapeutic agents for the treatment of such neurological diseases and other related disorders.
A pharmaceutical partnership between UCL and Takeda - A pioneering research collaboration for the treatment of neurodegenerative disease
UCL and Takeda Pharmaceutical Company Limited have formed a new research collaboration to identify and validate novel target genes for the treatment of neurodegenerative disease.